CARTsejtterápia
CARTsejtterápia, also known as CAR T-cell therapy, is an innovative treatment approach used in the field of oncology, particularly for certain types of cancer. The therapy involves the extraction of a patient's T-cells, which are then genetically modified in a laboratory to produce chimeric antigen receptors (CARs). These CARs are designed to recognize and bind to specific antigens on cancer cells, enabling the modified T-cells to target and destroy the cancer cells more effectively.
The process begins with the collection of the patient's peripheral blood mononuclear cells (PBMCs), which contain
Once the CAR T-cells have been generated, they are infused back into the patient. The infused CAR
CARTsejtterápia has shown promising results in the treatment of certain hematological malignancies, such as acute lymphoblastic